Shionogi Of Japan Files Quick Application For Peramivir Approval
This article was originally published in PharmAsia News
Japan's Shionogi plans to file for the first local approval of peramivir, which has emergency-use status in the United States to treat H1N1 flu
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.